Search results for "microarray."

showing 10 items of 384 documents

Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.

2008

Uveal melanoma is associated with a high mortality rate once metastases occur, with over >90% of metastatic patients dying within less than 1 year from metastases to the liver. The intraarterial hepatic (iah) administration of the alkylating agent fotemustine holds some promise with response rates of 36% and median survival of 15 months. Here, we investigated whether the DNA-repair-protein MGMT may be involved in the variability of response to fotemustine and temozolomide in uveal melanoma. Epigenetic inactivation of MGMT has been demonstrated to be a predictive marker for benefit from alkylating agent therapy in glioblastoma. We found a methylated MGMT promoter in 6% of liver metastases fr…

Uveal NeoplasmsCancer ResearchPathologymedicine.medical_specialtyProtein Array AnalysisAntineoplastic AgentsBiologyMetastasischemistry.chemical_compoundPredictive Value of TestsmedicineBiomarkers TumorHumansPromoter Regions GeneticneoplasmsDNA Modification MethylasesMelanomaTemozolomidePredictive markerTissue microarrayMelanomaTumor Suppressor ProteinsLiver NeoplasmsCancerDNA Methylationmedicine.diseaseImmunohistochemistrydigestive system diseasesNitrogen mustardDNA Repair EnzymesOncologychemistryCancer researchFotemustinemedicine.drugInternational journal of cancer
researchProduct

The role of NFkappaB inducing kinase (NIK) in the pathogenicity of EAE

2014

pathways (PTPN6, SLC3A2, VAV3, DDR1) and modulators of oxidative stress (MT1A, HMOX1, SLC30A1) were also significantly affected by the CBD treatment. The microarray results were confirmed using qPCR on selected gene targets. Immunoblotting demonstrated that CBD reduces IL-17 by decreasing STAT3 phosphorylation and increasing that of STAT5. In conclusion, our observations increase our understanding of the mechanisms of the anti-inflammatory activities of CBD.

VAV3DDR1MicroarrayKinaseImmunologyPTPN6Biologymedicine.disease_causedigestive systemdigestive system diseasesCell biologysurgical procedures operativeNeurologybiology.proteinmedicineImmunology and AllergyPhosphorylationNeurology (clinical)STAT3Oxidative stressJournal of Neuroimmunology
researchProduct

Convolutional architectures for virtual screening

2020

Abstract Background A Virtual Screening algorithm has to adapt to the different stages of this process. Early screening needs to ensure that all bioactive compounds are ranked in the first positions despite of the number of false positives, while a second screening round is aimed at increasing the prediction accuracy. Results A novel CNN architecture is presented to this aim, which predicts bioactivity of candidate compounds on CDK1 using a combination of molecular fingerprints as their vector representation, and has been trained suitably to achieve good results as regards both enrichment factor and accuracy in different screening modes (98.55% accuracy in active-only selection, and 98.88% …

Virtual screeningComputer sciencelcsh:Computer applications to medicine. Medical informaticsMachine learningcomputer.software_genre01 natural sciencesBiochemistryDrug design03 medical and health sciencesUser-Computer InterfaceStructural Biology0103 physical sciencesRepresentation (mathematics)lcsh:QH301-705.5Molecular BiologyBioactivity predictionSelection (genetic algorithm)030304 developmental biologySettore ING-INF/05 - Sistemi Di Elaborazione Delle Informazioni0303 health sciencesVirtual screening010304 chemical physicsbusiness.industryApplied MathematicsResearchProcess (computing)Deep learningComputer Science Applicationslcsh:Biology (General)Molecular fingerprintslcsh:R858-859.7Artificial intelligenceDNA microarraybusinesscomputerAlgorithmsBMC Bioinformatics
researchProduct

iGEMS : an integrated model for identification of alternative exon usage events

2016

DNA microarrays and RNAseq are complementary methods for studying RNA molecules. Current computational methods to determine alternative exon usage (AEU) using such data require impractical visual inspection and still yield high false-positive rates. Integrated Gene and Exon Model of Splicing (iGEMS) adapts a gene-level residuals model with a gene size adjusted false discovery rate and exon-level analysis to circumvent these limitations. iGEMS was applied to two new DNA microarray datasets, including the high coverage Human Transcriptome Arrays 2.0 and performance was validated using RT-qPCR. First, AEU was studied in adipocytes treated with (n = 9) or without (n = 8) the anti-diabetes drug,…

WHITE ADIPOCYTESPHYSICAL-ACTIVITYDIFFERENTIATIONARRAY ANALYSISSPLICE VARIANTSRNA-SEQ3111 BiomedicineHUMAN TISSUESTRANSCRIPTOMEalternative exon usageMICROARRAYS3142 Public health care science environmental and occupational healthGENE-EXPRESSION
researchProduct

Effects of postharvest partial dehydration and prolonged treatments with ethylene on transcript profiling in skins of wine grape berries.

2010

For certain food products, postharvest controlled stresses or treatments with specific elicitors are applied to induce desired physical/chemical changes and/or to positively affect phytochemical content. This is the case of wine grapes where both strategies, singularly applied or coupled, can be used to modulate berry composition and, as a consequence, affect wine quality traits. Since the knowledge of the effects of these postharvest treatments on berry metabolism and the regulation of gene expression is very limited, a large-scale transcriptome analysis has been carried out, using an oligo-based microarray (14,562 probes) on skins of wine grape (Vitis vinifera L.) berries subjected to deh…

Winefungifood and beveragesBerryHorticultureBiologymedicine.diseaseWine grapeTranscriptomeHorticulturegene expression genomics microarray polyphenols secondary metabolism transcriptome Vitis viniferaPhytochemicalPolyphenolSettore AGR/07 - Genetica AgrariamedicinePostharvestDehydrationNon disponibili
researchProduct

Identification of pathways involved in aneuploidy onset and its tolerance using a DNA microarray approach

2014

aneuploidy DNA microarray .Settore BIO/18 - Genetica
researchProduct

Metodologie Biomolecolari per la Conservazione e il Restauro

2011

biodeteriogeni biotecnologie molecolari DNA microbico PCR DNA microarraySettore BIO/11 - Biologia Molecolare
researchProduct

Caratterizzaione di consorzi microbici causa di deterioramento dei beni culturali e potenziali patogeni per l'uomo mediante analisi della molecola de…

2008

biodeterioramento biotecnologie patogeni PCR DNA microarraySettore BIO/11 - Biologia Molecolare
researchProduct

Inside Back Cover: Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures (Ch…

2017

biology010405 organic chemistryMicroarray analysis techniquesStereochemistryChemistryOrganic ChemistryMucinGeneral Chemistry010402 general chemistry01 natural sciencesCatalysis0104 chemical sciencesBiochemistrybiology.proteinAntibodyDNA microarrayChemistry - A European Journal
researchProduct

Cover Picture: Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays to Evaluate Serum- and Monoclonal-Antibody Specificity (Angew. Chem. Int.…

2009

biologyChemistrymedicine.drug_classGeneral ChemistryMonoclonal antibodyMolecular biologyCatalysisGlycopeptideSolid-phase synthesisTandem repeatbiology.proteinmedicineCover (algebra)DNA microarrayAntibodyMUC1Angewandte Chemie International Edition
researchProduct